By dual PPAR-γ/FOXO1 regulation, miR-223 shifted macrophages toward an anti-inflammatory M2 phenotype, attenuating colonic inflammation and tissue damage in DSS-induced colitis (Figure 9). Here, PPARG is linked to colitis.